EWI News 16.48 09/08/2014 04:49:46 Italy Index MSCI Ishares

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Italy Index MSCI Ishares (EWI) 16.48 $EWI

Look for Shares of iShares MSCI Italy Index Fund to Potentially Pullback after Yesterday's 1.78% Rise
Comtex SmarTrend(R) - Mon Aug 25, 5:07PM CDT
iShares MSCI Italy Index Fund (NYSE:EWI) traded in a range yesterday that spanned from a low of $15.85 to a high of $16.03. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $15.79 on volume of 6.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

iShares MSCI Italy Index Fund Set to Possibly Pullback After Yesterday's Rally of 1.94%
Comtex SmarTrend(R) - Thu Aug 21, 5:04PM CDT
iShares MSCI Italy Index Fund (NYSE:EWI) traded in a range yesterday that spanned from a low of $15.64 to a high of $15.79. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of $15.64 on volume of 3.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

3 European ETFs Crushed by Fresh Banking Woes - ETF News And Commentary
Zacks Equity Research - ZACKS - Mon Aug 18, 11:00AM CDT
These European ETFs have been hit hard by the latest round of banking worries.

iShares MSCI Italy Index Fund Falls 1.14% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed Aug 06, 4:12PM CDT
iShares MSCI Italy Index Fund (NYSE:EWI) traded in a range yesterday that spanned from a low of $15.49 to a high of $15.63. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $15.70 on volume of 19.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Look for Shares of iShares MSCI Italy Index Fund to Potentially Rebound after Yesterday's 2.25% Sell Off
Comtex SmarTrend(R) - Tue Jul 08, 5:40PM CDT
iShares MSCI Italy Index Fund (NYSE:EWI) traded in a range yesterday that spanned from a low of $16.70 to a high of $17.01. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $17.29 on volume of 8.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

iShares MSCI Italy Index Fund Set to Possibly Rebound After Yesterday's Selloff of 1.13%
Comtex SmarTrend(R) - Wed Jun 25, 4:58PM CDT
iShares MSCI Italy Index Fund (NYSE:EWI) traded in a range yesterday that spanned from a low of $17.39 to a high of $17.55. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $17.69 on volume of 4.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

iShares MSCI Italy Index Fund Up 12.1% Since SmarTrend Uptrend Call (EWI)
Comtex SmarTrend(R) - Mon Mar 31, 10:03AM CDT
SmarTrend identified an Uptrend for iShares MSCI Italy Index Fund (NYSE:EWI) on January 10th, 2014 at $15.86. In approximately 3 months, iShares MSCI Italy Index Fund has returned 12.08% as of today's recent price of $17.77.

Play the PIIGS Recovery with These European ETFs - ETF News And Commentary
Zacks Equity Research - ZACKS - Mon Mar 31, 9:01AM CDT
This group of country ETFs has been soaring and could be a solid choice for investors seeking Europe exposure.

iShares MSCI Italy Index Fund Rises 1.45% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Mar 05, 5:43PM CST
iShares MSCI Italy Index Fund (NYSE:EWI) traded in a range yesterday that spanned from a low of $16.69 to a high of $16.88. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $16.72 on volume of 6.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Euro Market Dip, Rebound Reflect Italian P.M. Row
at Investor's Business Daily - Thu Feb 13, 5:10PM CST
London's FTSE 100 index snapped a five-day advance Thursday, while the CAC-40 index in Paris reversed early losses to add a seventh day to its uptrend. Frankfurt's DAX index also reversed, climbing 0.6% in its fourth gain in five days. The recent...

Foreign Stocks Soar As Fed Opts To Maintain Bond-Buying Pace
at Investor's Business Daily - Wed Sep 18, 5:30PM CDT
ETF action Wednesday suggests that the impact of the Fed's no-taper decision will be far greater abroad than in the U.S. Certainly the news that the Federal Reserve won't back off from its $85 billion-per-month bond-buying program was felt on the...

iShares MSCI Italy Index Fund (EWI) : Take profit @ $13.63
Trading Central - Tue Sep 10, 8:41AM CDT
On a relative basis against the IVV S&P500, the iShares MSCI Italy Capped ETF is losing upward momentum, we prefer to take profit right now at last price ($13.63) and to close our long position opened on August 29th at last price. Trading strategy: ...

iShares MSCI Italy Index Fund (EWI) : Buy @ $13.23
Trading Central - Thu Aug 29, 1:12PM CDT
From a technical view, the ETF is shaping a tentative Head & Soulders pattern which is a bullish configuration. Regarding technical indicators, the weekly RSI has pushed above a bearish trend line while the weekly MACD is reversing up from a...

4 Outperforming ETFs Leading Europe Higher - ETF News And Commentary
Eric Dutram - ZACKS - Thu Aug 22, 9:00AM CDT
Believe it or not but these four Europe ETFs are leading the markets higher.

3 Ways Income Investors Get in Trouble
Ron DeLegge - ETFG - Sat May 11, 3:43AM CDT
A bull market in lunacy is one way to describe today\'s bond market.

Big Gains in Greece ETF, Can It Last? - ETF News And Commentary
Eric Dutram - Zacks Investment Research - Tue Apr 09, 2:30PM CDT
GREK is rallying today on hopes for its troubled banking sector, can this trend continue?

Are European Stocks Oversold?
Ron DeLegge - ETFG - Tue Mar 26, 12:13AM CDT
Before you buy into the claim that stocks in the Eurozone are oversold, let's examine the facts. Do valuations and performance figures support these claims?
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 79

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 421

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 134

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 72

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 140

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 93

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 149

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 312

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 87

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading

Top 5 Most Recently Viewed Articles

Kohl's Stock Plummets Amid Retail Challenges and Restructuring

Updated Category News Views 589

Kohl's Corporation Faces Significant Challenges Kohl's Corporation (NYSE: KSS) has recently seen its stock plummet to a concerning 52-week low of $13.61. This decline paints a grim picture of the current retail environment, where shifting consumer habits and fierce competition play a pivotal role. Priced at just 0.4 times book value and boasting a generous 14.5% dividend...

Continue Reading
Rapid Micro Biosystems Achieves Record Growth and Future Outlook

Updated Category News Views 136

Financial Performance Highlights for Rapid Micro Biosystems Rapid Micro Biosystems, Inc. (NASDAQ: RPID) has announced impressive results for the fourth quarter and the entire fiscal year of 2024. The company recorded a total revenue of $8.2 million in the fourth quarter, marking a 30% increase compared to the same period in 2023. Likewise, the full year revenue reached...

Continue Reading
ALZpath and Siemens Team Up for Advanced Alzheimer's Testing

Updated Category News Views 265

ALZpath and Siemens Healthineers Form Strategic Partnership ALZpath is thrilled to announce a significant licensing agreement with Siemens Healthineers. This collaboration marks a pivotal enhancement in the accessibility of diagnostic testing for Alzheimer's disease. The agreement involves the use of ALZpath's proprietary pTau217 antibody, a remarkable tool for...

Continue Reading
Generate:Biomedicines Showcases Promising Results for GB-0895

Updated Category News Views 495

Results from Phase 1 Trials of GB-0895 Unveiled Generate:Biomedicines is making notable headlines with its innovative drug GB-0895. This cutting-edge treatment is an ultra-high affinity anti-TSLP monoclonal antibody, specifically designed for individuals grappling with asthma. With a unique formulation, GB-0895 offers a prolonged half-life and sustained pharmacological...

Continue Reading
Driving Growth in Natural Stone Market and Its Future

Updated Category News Views 226

Steady Growth in the Natural Stone Market The natural stone market is on a promising upward trajectory, predicted to rise from USD 37.89 billion to USD 47.63 billion by a future date, indicating a compound annual growth rate (CAGR) of 4.68%. Various factors are driving this growth, most notably the intense infrastructure investment blooming worldwide. The construction...

Continue Reading